Gómez Marcos Manuel A, García Ortiz Luis, González Elena Luis Javier, Sánchez Rodríguez Angel
Centro de Salud de Garrido Sur, Salamanca, España.
Aten Primaria. 2006 May 31;37(9):498-503. doi: 10.1157/13089094.
To evaluate the effectiveness of an intervention on health workers, based on quality improvement through reduction of cardiovascular risk in patients with hypertension.
Quasi-experimental study.
Primary care. Two urban health centres.
A thousand hypertense patients selected by stratified random sampling. One centre (500) was assigned to implement a quality improvement intervention, while at the other centre (500) "usual care" procedures were followed (control group).
The quality improvement intervention consisted of a combined program designed for the medical and nursing staff that comprised audit, feedback, training sessions, and implementation of clinical practice guidelines.
Coronary risk using the Framingham scale and cardiovascular mortality risk using the SCORE project.
Absolute coronary risk decreased from 16.94% (95% CI, 15.92-17.66) to 13.81% (95% CI, 13.09-14.52) (P<.001) in the intervention group; whilst there was no significant change in the control group, which dropped from 17.63% (95% CI, 16.68-18.53) to 16.82% (95% CI, 15.91-17.74). The intervention led to a 2.28% point decrease (95% CI, 1.35-3.21) (P<.001) in coronary risk. Cardiovascular mortality risk decreased from 2.48% (95% CI, 2.35-2.62) to 2.19% (95% CI, 2.07-2.31) (P<.001) in the intervention group, with no significant change in the control group, which changed from 2.45% (95% CI, 2.30-2.59) to 2.52% (95% CI, 2.38-2.66). The intervention led to a 0.36% point decrease (95% CI, 0.05-0.73) (P<.001) in cardiovascular mortality risk.
The quality improvement intervention was effective in decreasing coronary risk and cardiovascular mortality risk in patients with hypertension.
通过降低高血压患者的心血管风险来改进医疗质量,进而评估针对医护人员的一项干预措施的效果。
准实验研究。
初级保健机构。两家城市健康中心。
通过分层随机抽样选取的1000名高血压患者。其中一个中心(500名患者)被指定实施质量改进干预措施,而另一个中心(500名患者)则遵循“常规护理”程序(对照组)。
质量改进干预措施包括为医护人员设计的一个综合项目,该项目包括审核、反馈、培训课程以及临床实践指南的实施。
使用弗雷明汉量表评估冠心病风险,使用SCORE项目评估心血管疾病死亡风险。
干预组的绝对冠心病风险从16.94%(95%可信区间,15.92 - 17.66)降至13.81%(95%可信区间,13.09 - 14.52)(P <.001);而对照组无显著变化,从17.63%(95%可信区间,16.68 - 18.53)降至16.82%(95%可信区间,15.91 - 17.74)。该干预措施使冠心病风险降低了2.28个百分点(95%可信区间,1.35 - 3.21)(P <.001)。干预组的心血管疾病死亡风险从2.48%(95%可信区间,2.35 - 2.62)降至2.19%(95%可信区间,2.07 - 2.31)(P <.001),对照组无显著变化,从2.45%(95%可信区间,2.30 - 2.59)变为2.52%(95%可信区间,2.38 - 2.66)。该干预措施使心血管疾病死亡风险降低了0.36个百分点(95%可信区间,0.05 - 0.73)(P <.001)。
质量改进干预措施在降低高血压患者的冠心病风险和心血管疾病死亡风险方面是有效的。